Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Why Is Innoviz Technologies (INVZ) Stock Down -18.31% Today?

Why Is Innoviz Technologies (INVZ) Stock Down -18.31% Today?

Key Takeaways

  • Shares of INVZ are down 18.31% in Thursday's session, trading at $0.1182 versus the prior close of $0.1447.
  • The primary catalyst is the company's 1-for-20 reverse share split, announced after Wednesday's close, aimed at restoring compliance with Nasdaq's $1.00 minimum bid price requirement.
  • Secondary pressure comes from a deteriorating analyst backdrop: JPMorgan moved to Neutral on November 12, and Goldman Sachs halved its price target to $0.20 on November 16 while keeping a Neutral rating.
  • The stock is still working through the fallout from a third-quarter revenue miss and a lowered full-year outlook disclosed on November 11.
  • Fellow LiDAR names traded only modestly lower, confirming the sell-off is company-specific rather than a sector-wide de-rating.
  • Volume is running well above normal, with roughly 3.6 million shares changing hands by early afternoon against a three-month average near 3.0 million.
  • News Significance Score: 58/100 - A material listing-compliance reverse split met a move more than four times the stock's typical daily swing.
  • Traders can review detailed Price Targets, Earnings history, and Forecast data on the dedicated Tickeron pages.
  • For systematic strategy ideas across this and thousands of other symbols, explore Trending AI Robots.

Opening Summary

Innoviz Technologies Ltd. (INVZ) is a Tel Aviv-based developer of automotive-grade solid-state LiDAR sensors and perception software, sold to automakers and, increasingly, to defense and homeland security customers under its Perciz brand. Shares are trading at $0.1182, down 18.31% from the previous session's close of $0.1447, in a clearly negative move. The immediate cause is verified: late Wednesday the company announced a 1-for-20 reverse share split, the maximum ratio authorized by shareholders, designed to lift the share price back above Nasdaq's $1.00 minimum bid threshold. The stock has now lost roughly two-thirds of its value since mid-September.

Why the Reverse Split Sparked Heavy Selling

Innoviz confirmed that the 1-for-20 split takes effect at 11:59 p.m. Eastern on Friday, December 4, 2026, with split-adjusted trading beginning at the Nasdaq open on Monday, December 7 under the same INVZ symbol and a new CUSIP. Outstanding shares will fall from approximately 299.5 million to roughly 15 million, and authorized share capital will drop from 500 million to 25 million ordinary shares.

The mechanical effect is cosmetic — market capitalization and each holder's percentage ownership are unchanged apart from fractional-share handling. The market reaction, however, reflects what the filing signals. Rather than opting for a smaller ratio, the board selected the maximum 1-for-20 authorized at the September 16 annual general meeting, underscoring the depth of the listing problem. The company also stated plainly that there can be no assurance the split will achieve or sustain compliance, leaving open the possibility of a fresh deficiency notice if the adjusted price slips back below $1.00.

For a heavily shorted, deeply speculative micro-cap, that combination — a maximum-ratio split, an explicit warning, and no operational news attached — is a clear negative signal. Investors have historically treated reverse splits by cash-burning small caps as confirmation of structural weakness rather than a solution.

Analyst Downgrades and the Post-Earnings Reset

The split landed on top of an already weakened narrative. On November 11, Innoviz reported third-quarter revenue of $12.1 million, down from $15.3 million a year earlier and well short of consensus, after a customer pushed its start-of-production timeline into 2027 and shifted a large block of engineering revenue with it. Gross margin was negative 10.3%, cash burn accelerated to $21.4 million, and full-year revenue guidance was reset to $44 million–$46 million. Management is cutting roughly 20% of its workforce as part of a realignment targeting about $17.5 million in annualized savings, and ended the quarter with $54.4 million in cash and equivalents and no long-term debt.

Analysts responded within days. JPMorgan downgraded the stock to Neutral from Overweight on November 12, and Goldman Sachs kept a Neutral rating while cutting its target to $0.20 from $0.40 on November 16 — a level the shares have now breached on an adjusted basis. Consensus sits at Hold with an average target near $0.20.

Market Context and Trading Activity

Innoviz opened Thursday at $0.113, briefly touched $0.107, and has since recovered into the $0.11–$0.12 range, but it remains far below the $0.1447 prior close. The stock sits beneath both its 20-day and 60-day moving averages and is pressing against the lower end of its 52-week range, having fallen from about $0.40 in mid-September.

The move is company-specific. LiDAR peers such as MVIS and OUST traded only modestly lower, and broader indices showed no comparable weakness. Volume confirms conviction behind the selling rather than a thin, order-book-driven print, with turnover already exceeding a full average session by early afternoon.

News Significance Score

The score runs from 0 — no meaningful news and a routine price move — to 100, meaning transformative news paired with an extreme, rare move. Innoviz lands at 58 out of 100.

The verified news is material but not transformative: a reverse split is a listing-compliance step, not an operating result, though choosing the maximum 1-for-20 ratio and warning about sustained compliance raises its weight relative to a company now worth roughly $35 million. The price action was highly unusual — today's decline of 18.31% is about 4.5 times the stock's average absolute daily move of roughly 4.0% and is larger than any single session in the past 60, with volume amplifying the signal. Moderate news plus a rare move produces the mid-range score.

What Comes Next for INVZ

All attention now shifts to Monday, December 7, when split-adjusted trading begins. Whether the shares hold above $1.00 on that date — theoretically near $2.40 based on current levels — will determine if the compliance issue is resolved or merely deferred, since a sustained sub-$1.00 price would invite another deficiency notice. Investors will also watch for the December quarter's revenue print against the $44 million–$46 million full-year target, progress converting defense and counter-UAS pilots into volume orders expected in the first half of 2027, and whether the 20% workforce reduction delivers the promised savings without disrupting customer programs. The principal risks remain continued cash burn, negative gross margins, NRE timing uncertainty, and the possibility of additional capital raising that would dilute holders already down more than 80% this year.

Trending AI Robots

Tickeron's Trending AI Robots page curates the AI trading bots performing strongest under present market conditions, drawn from a library of hundreds of bots covering thousands of tickers. Each bot differs by strategy, timeframe, performance metrics, and the symbols it trades, so results vary widely across market environments. The trending section narrows that universe to the systems currently generating the most consistent output. Review the live rankings to see which strategies are working right now and how they compare before allocating capital.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: INVZ

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


INVZ in upward trend: price expected to rise as it breaks its lower Bollinger Band on November 19, 2026

INVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 39 of 42 cases where INVZ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +13.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVZ advanced for three days, in 188 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVZ as a result. In 66 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The Moving Average Convergence Divergence Histogram (MACD) for INVZ turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 36 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for INVZ entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.285) is normal, around the industry mean (0.781). P/E Ratio (-0.553) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.236) is also within normal values, averaging (49.456).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. INVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

Notable companies

The most notable companies in this group are AutoZone (NYSE:AZO), Advance Auto Parts (NYSE:AAP), Goodyear Tire & Rubber Company (The) (NASDAQ:GT).

Industry description

OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.

Market Cap

The average market capitalization across the Auto Parts: OEM Industry is 4.82B. The market cap for tickers in the group ranges from 1.93K to 72.72B. ORLY holds the highest valuation in this group at 72.72B. The lowest valued company is CREVF at 1.93K.

High and low price notable news

The average weekly price growth across all stocks in the Auto Parts: OEM Industry was -6%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was -25%. SYPR experienced the highest price growth at 10%, while MKDW experienced the biggest fall at -55%.

Volume

The average weekly volume growth across all stocks in the Auto Parts: OEM Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 41
P/E Growth Rating: 47
Price Growth Rating: 65
SMR Rating: 78
Profit Risk Rating: 89
Seasonality Score: 9 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AutoPartsOEM

Industry
N/A
Address
5 Uri Ariav street
Phone
+972 747003692
Employees
372
Web
https://www.innoviz.tech
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.